Skip to main content
Erschienen in: ästhetische dermatologie & kosmetologie 4/2019

21.08.2019 | Filler | fortbildung

Eigenschaften, Anwendung und Komplikationen

Dermatofiller in der ästhetischen Medizin

verfasst von: Dr. med. Annegret Dörre

Erschienen in: ästhetische dermatologie & kosmetologie | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Minimalinvasive Verfahren nehmen einen hohen Stellenwert in der ästhetischen Medizin ein und die Zahl der Anwendungen ist weltweit in den letzten Jahren deutlich gewachsen. Die Injektion von Dermatofillern ist dabei neben der Botulinumtoxin-Injektion die wichtigste Behandlungsmethode.
Literatur
1.
Zurück zum Zitat Aple RS et al. Acute choroidal infarction following subcutaneous injection of micronized dermal matrixin the forehead region. Retina. 2003; 23: 552–4 CrossRef Aple RS et al. Acute choroidal infarction following subcutaneous injection of micronized dermal matrixin the forehead region. Retina. 2003; 23: 552–4 CrossRef
2.
Zurück zum Zitat Artzi O et al. Resistant and recurrent late reaction to hyaluronic acid-based gel. Dermatol Surg. 2016; 42: 31–7 CrossRef Artzi O et al. Resistant and recurrent late reaction to hyaluronic acid-based gel. Dermatol Surg. 2016; 42: 31–7 CrossRef
3.
Zurück zum Zitat Bjarnsholt T et al. Detection of bacteria by fluorescene in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg. 2009; 35: 1620–4 CrossRef Bjarnsholt T et al. Detection of bacteria by fluorescene in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg. 2009; 35: 1620–4 CrossRef
4.
Zurück zum Zitat Carruthers A et al. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Dermatol Surg. 2010; 36: 2121–34 CrossRef Carruthers A et al. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Dermatol Surg. 2010; 36: 2121–34 CrossRef
5.
Zurück zum Zitat Cassuto D. The use of Dermicol-P35 dermal filler for nonsurgical rhinoplasty. Aesthet Surg J. 2009; 29: 22–4 CrossRef Cassuto D. The use of Dermicol-P35 dermal filler for nonsurgical rhinoplasty. Aesthet Surg J. 2009; 29: 22–4 CrossRef
6.
Zurück zum Zitat Douse-Dean T, Jacob CI. Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid. J Drugs Dermatol. 2008; 7: 281–3 PubMed Douse-Dean T, Jacob CI. Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid. J Drugs Dermatol. 2008; 7: 281–3 PubMed
7.
Zurück zum Zitat Funt DK. Avoiding malar edema during midface/cheek augmentation with dermal fillers. J Clin Aesthet Dermatol. 2011; 4: 32–6 PubMedPubMedCentral Funt DK. Avoiding malar edema during midface/cheek augmentation with dermal fillers. J Clin Aesthet Dermatol. 2011; 4: 32–6 PubMedPubMedCentral
8.
Zurück zum Zitat Griepentrog GJ et al. Periorbital edema following hyaluronic acid gel injection: a retrospective review. Am J Cosmet Surg. 2011; 28: 251–4 CrossRef Griepentrog GJ et al. Periorbital edema following hyaluronic acid gel injection: a retrospective review. Am J Cosmet Surg. 2011; 28: 251–4 CrossRef
10.
Zurück zum Zitat Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2.year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013; 39: 1602 CrossRef Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2.year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013; 39: 1602 CrossRef
11.
Zurück zum Zitat Kim YJ, Choi KS. Bilateral blindness after filler injection. Plast Reconstr Surg. 2013; 131: 298e–299e CrossRef Kim YJ, Choi KS. Bilateral blindness after filler injection. Plast Reconstr Surg. 2013; 131: 298e–299e CrossRef
12.
Zurück zum Zitat Kim DW et al. Vascular complications of hyaluronic acid fillers and the role of hyaluroniadase in management. J Plast Reconstr Aesthet Surg. 2011; 64: 1590–5 CrossRef Kim DW et al. Vascular complications of hyaluronic acid fillers and the role of hyaluroniadase in management. J Plast Reconstr Aesthet Surg. 2011; 64: 1590–5 CrossRef
13.
Zurück zum Zitat Marusza W et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012; 7: 1441–7 PubMedPubMedCentral Marusza W et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012; 7: 1441–7 PubMedPubMedCentral
14.
Zurück zum Zitat Pessa JE, Garza JR. The malar septum: the anatomic basis of malar mounds and malar edema. Aesthet Surg J. 1997; 17: 11–7 CrossRef Pessa JE, Garza JR. The malar septum: the anatomic basis of malar mounds and malar edema. Aesthet Surg J. 1997; 17: 11–7 CrossRef
15.
Zurück zum Zitat Rohrich RJ, Pessa JE. The retaining system of the face: histologic evaluation of the septal boundaries of the subcutaneous fat compartments. Plast Reconstr Surg. 2008; 121: 1804–9 CrossRef Rohrich RJ, Pessa JE. The retaining system of the face: histologic evaluation of the septal boundaries of the subcutaneous fat compartments. Plast Reconstr Surg. 2008; 121: 1804–9 CrossRef
16.
Zurück zum Zitat Rosner M et al. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg. 2009; 35: 367–74 CrossRef Rosner M et al. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg. 2009; 35: 367–74 CrossRef
17.
Zurück zum Zitat Rzany B, Bachmann F, Nast A. Injectable fillers: adverse reactions and their management. Hautarzt. 2013; 64: 117–25 CrossRef Rzany B, Bachmann F, Nast A. Injectable fillers: adverse reactions and their management. Hautarzt. 2013; 64: 117–25 CrossRef
18.
Zurück zum Zitat Signorini M et al. Global aesthetics consensus group. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016; 137: 961e–971e CrossRef Signorini M et al. Global aesthetics consensus group. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016; 137: 961e–971e CrossRef
19.
Zurück zum Zitat Sperling B et al. The current state of treatment of adverse reactions to injectable fillers. Dermatol Surg. 2010; 36: 1895–904 CrossRef Sperling B et al. The current state of treatment of adverse reactions to injectable fillers. Dermatol Surg. 2010; 36: 1895–904 CrossRef
Metadaten
Titel
Eigenschaften, Anwendung und Komplikationen
Dermatofiller in der ästhetischen Medizin
verfasst von
Dr. med. Annegret Dörre
Publikationsdatum
21.08.2019
Verlag
Springer Medizin
Schlagwort
Filler
Erschienen in
ästhetische dermatologie & kosmetologie / Ausgabe 4/2019
Print ISSN: 1867-481X
Elektronische ISSN: 2198-6517
DOI
https://doi.org/10.1007/s12634-019-0070-3

Weitere Artikel der Ausgabe 4/2019

ästhetische dermatologie & kosmetologie 4/2019 Zur Ausgabe

kurz & knapp

kurz & knapp

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.